Funded Grants

One percent of Alzheimer’s disease is the early-onset type that runs in families.

A treatment or prevention of Alzheimer’s disease is a top priority for medical science.

Individuals with Alzheimer’s suffer severe memory loss over time, and eventually are completely dependent on caregivers.

Brain cancer is the most common type of solid cancer in children in Canada, and medulloblastoma is the most common malignant brain cancer of childhood.

Cancer can exhibit relentless growth and relapse because of the enhanced protection of its chromosome ends.

Dr David Stojdl’s lab has custom‑built an oncolytic virus biotherapy specifically for the treatment of the devastating brain cancer, glioblastoma multiforme (GBM).

In childhood, medulloblastoma (a form of brain cancer) and neuroblastoma (a cancer that starts in the nerve cells) can be aggressive and hard to treat.

500,000 Canadians have dementia, a number that will double within a generation due to the ongoing aging demographics of the population, with annual costs estimated to increase from $15B currently to over $150B by the year 2050.

Ms. Nancy Butcher, is a doctoral candidate who is conducting research using advanced brain imaging techniques to measure levels of the brain chemical dopamine, to differentiate between Parkinson’s disease and other motor neuron defects.

The CIFAR Learning in Machines & Brains program brings together 41 researchers to examine what consciousness is and how it comes about.